Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 44 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic, Supportive care, Treatment				Active				40 to 65				Other				2004/949 NCT00111241


2.		STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Other				STARS-Pilot (05/55 Graham) NCT00126360


3.		Arimidex Neoadjuvant in Operable Breast Cancer in Post-Menopausal Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Postmenopausal to 65				Pharmaceutical / Industry				1033MX/001 NCT00262535


4.		Arthralgia During Anastrozole Therapy for Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Pharmaceutical / Industry				D5392L00013 2005-00-5441-19 EUDRACT number, NCT00323479


5.		Liver Safety Under Upfront Arimidex vs Tamoxifen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				Not specified				Pharmaceutical / Industry				D5392L00023 NCT00537771


6.		Second-Line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				not specified				Other				N07MAN Eudract 2007-007030-20, NCT00684216


7.		Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				65 and over				Other				0120070323 NCT00698971

Last Modified: 4/29/2008 First Published: 10/25/2003


8.		Phase III Randomized Study of Adjuvant Tamoxifen Versus Anastrozole in Postmenopausal Women With Ductal Carcinoma In Situ

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				40 to 70				Other				CRUK-IBIS-II-DCIS EU-20226, BIG-5-02, NCT00072462, IBCSG-31-03-DCIS, ISRCTN31488319

Last Modified: 1/14/2009 First Published: 12/23/2003


9.		Phase III Randomized Study of Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Postmenopausal				NCI				SWOG-S0226 CAN-NCIC-MAC7, S0226, NCT00075764


10.		Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				Postmenopausal				Other				ALCC 04.02 NCT00122356

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute